ID   CA1_CONAH               Reviewed;          66 AA.
AC   P0CH24;
DT   10-AUG-2010, integrated into UniProtKB/Swiss-Prot.
DT   10-AUG-2010, sequence version 1.
DT   02-DEC-2020, entry version 20.
DE   RecName: Full=Conopeptide-Ac1 {ECO:0000305};
DE   AltName: Full=5P1 {ECO:0000303|PubMed:32111068};
DE   AltName: Full=5P2 {ECO:0000303|PubMed:32111068};
DE   AltName: Full=Conopeptide Ac3.1 {ECO:0000303|PubMed:20307606};
DE   AltName: Full=Conotoxin-Ac1 {ECO:0000303|PubMed:32111068};
DE   AltName: Full=Conotoxin-Ac1-O6P {ECO:0000303|PubMed:32111068};
DE   Flags: Precursor; Fragment;
OS   Conus achatinus (Little frog cone).
OC   Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Gastropoda;
OC   Caenogastropoda; Neogastropoda; Conoidea; Conidae; Conus; Pionoconus.
OX   NCBI_TaxID=369967;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Venom duct;
RX   PubMed=20307606; DOI=10.1016/j.peptides.2010.03.010;
RA   Wu X.-C., Zhou M., Peng C., Shao X.-X., Guo Z.-Y., Chi C.-W.;
RT   "Novel conopeptides in a form of disulfide-crosslinked dimer.";
RL   Peptides 31:1001-1006(2010).
RN   [2]
RP   PROTEIN SEQUENCE OF 52-66, SYNTHESIS OF 52-66, FUNCTION, HYDROXYLATION AT
RP   PRO-57 AND PRO-60, D-AMINO ACID AT TRP-64, MASS SPECTROMETRY, SUBCELLULAR
RP   LOCATION, AND BIOASSAY.
RC   TISSUE=Venom;
RX   PubMed=32111068; DOI=10.3390/md18030135;
RA   Liu X., Yao G., Wang K., Liu Y., Wan X., Jiang H.;
RT   "Structural and functional characterization of conotoxins from Conus
RT   achatinus targeting NMDAR.";
RL   Mar. Drugs 18:0-0(2020).
CC   -!- FUNCTION: Ac1 weakly inhibits N-methyl-D-aspartate receptor subunit 2B
CC       (NR2B) (IC(50)=8.22 uM). In vivo, shortens sleep latency and extends
CC       sleep time after lateral brain administration. Is more potent than Ac1-
CC       O6P for these effects. Also has an analgesic activity similar to that
CC       of Ac1-O6P. {ECO:0000269|PubMed:32111068}.
CC   -!- FUNCTION: Ac1-O6P has no or very weak activity on voltage-gated
CC       channels and receptors tested. In vivo, shortens sleep latency and
CC       extends sleep time after lateral brain administration. Is less potent
CC       than Ac1 for these effects. Also has an analgesic activity similar to
CC       that of Ac1. {ECO:0000269|PubMed:32111068}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:32111068}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom duct.
CC       {ECO:0000305|PubMed:32111068}.
CC   -!- PTM: Ac1-O6P is hydroxylated once at Pro-60, whereas Ac1 is
CC       hydroxylated at both Pro-57 and Pro-60. Trp-64 is supposed to be a D-
CC       amino acid in Ac1-O6P. {ECO:0000269|PubMed:32111068}.
CC   -!- PTM: Hydroxylation at Pro-57 is important for activity on N-methyl-D-
CC       aspartate receptors, since Ac1 is 5-fold more potent than Ac1 on
CC       NR2A/GRIN2A and NR2B/GRIN2B N-methyl-D-aspartate (NMDA) receptors.
CC       {ECO:0000269|PubMed:32111068}.
CC   -!- PTM: Synthetic peptides with carboxylated glutamate residues instead of
CC       Glu-61 and Trp-65, with an optional amidation of Thr-66 show a higher
CC       analgesic activity than morphine. {ECO:0000269|PubMed:32111068}.
CC   -!- MASS SPECTROMETRY: Mass=1992.11; Method=MALDI; Note=Hydroxylated at
CC       Pro-57 (Ac1).; Evidence={ECO:0000269|PubMed:32111068};
CC   -!- MASS SPECTROMETRY: Mass=1976.11; Method=MALDI; Note=Not hydroxylated at
CC       Pro-57 (Ac1-O6P).; Evidence={ECO:0000269|PubMed:32111068};
CC   -!- MISCELLANEOUS: The mature peptide does not contain cysteine residue.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: Ac1 has no or very weak activity on voltage-gated sodium
CC       channel, voltage-gated potassium channel, voltage-gated calcium
CC       channels, and NR2A/GRIN2A N-methyl-D-aspartate (NMDA) receptors.
CC       {ECO:0000269|PubMed:32111068}.
CC   -!- MISCELLANEOUS: Ac1-O6P has no or very weak activity on voltage-gated
CC       sodium channel, voltage-gated potassium channel, voltage-gated calcium
CC       channels, NR2A/GRIN2A and NR2B/GRIN2B N-methyl-D-aspartate (NMDA)
CC       receptors. {ECO:0000269|PubMed:32111068}.
CC   -!- SIMILARITY: Belongs to the conotoxin A superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   SMR; P0CH24; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0035792; C:host cell postsynaptic membrane; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Cleavage on pair of basic residues; D-amino acid;
KW   Direct protein sequencing; Hydroxylation; Ion channel impairing toxin;
KW   Ionotropic glutamate receptor inhibitor; Neurotoxin;
KW   Postsynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL          <1..17
FT                   /evidence="ECO:0000255"
FT   PROPEP          18..51
FT                   /evidence="ECO:0000269|PubMed:32111068"
FT                   /id="PRO_0000397196"
FT   PEPTIDE         52..66
FT                   /note="Conopeptide-Ac1"
FT                   /evidence="ECO:0000269|PubMed:32111068"
FT                   /id="PRO_0000397197"
FT   MOD_RES         57
FT                   /note="Hydroxyproline; partial"
FT                   /evidence="ECO:0000269|PubMed:32111068"
FT   MOD_RES         60
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000269|PubMed:32111068"
FT   MOD_RES         64
FT                   /note="D-tryptophan; partial"
FT                   /evidence="ECO:0000305|PubMed:32111068"
FT   NON_TER         1
SQ   SEQUENCE   66 AA;  7860 MW;  8B30FF5CBC9B73F7 CRC64;
     LGVLVTIFLV LFPMATLQLD GDQTADRHAG ERDQDPLEQY RNLKHVLRRT RNYYLYPARP
     ENSWWT
//
